131 related articles for article (PubMed ID: 7858153)
21. [Cytokines and malignant lymphomas].
Feller AC; Merz H
Verh Dtsch Ges Pathol; 1992; 76():70-8. PubMed ID: 1283279
[TBL] [Abstract][Full Text] [Related]
22. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
23. Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas.
Hsu SM; Xie SS; Waldron JA
Am J Pathol; 1992 Oct; 141(4):915-23. PubMed ID: 1415484
[TBL] [Abstract][Full Text] [Related]
24. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma.
Cattaruzza L; Gloghini A; Olivo K; Di Francia R; Lorenzon D; De Filippi R; Carbone A; Colombatti A; Pinto A; Aldinucci D
Int J Cancer; 2009 Sep; 125(5):1092-101. PubMed ID: 19391137
[TBL] [Abstract][Full Text] [Related]
25. Paraffin-immunohistochemical analysis of 226 non-Hodgkin's malignant lymphomas in the endemic area of human T-cell leukemia virus type 1.
Hasui K
Acta Pathol Jpn; 1991 May; 41(5):350-62. PubMed ID: 1867099
[TBL] [Abstract][Full Text] [Related]
26. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
27. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
[TBL] [Abstract][Full Text] [Related]
28. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas.
Carbone A; Cozzi M; Gloghini A; Pinto A
Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin's disease: a cytokine-producing tumor--a review.
Gruss HJ; Herrmann F; Drexler HG
Crit Rev Oncog; 1994; 5(5):473-538. PubMed ID: 8519809
[TBL] [Abstract][Full Text] [Related]
30. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
31. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
33. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
34. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
35. The role of interleukin-3 in classical Hodgkin's disease.
Aldinucci D; Olivo K; Lorenzon D; Poletto D; Gloghini A; Carbone A; Pinto A
Leuk Lymphoma; 2005 Mar; 46(3):303-11. PubMed ID: 15621820
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
37. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease.
Van Gool SW; Delabie J; Vandenberghe P; Coorevits L; De Wolf-Peeters C; Ceuppens JL
Leukemia; 1997 Jun; 11(6):846-51. PubMed ID: 9177439
[TBL] [Abstract][Full Text] [Related]
38. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
39. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
[TBL] [Abstract][Full Text] [Related]
40. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells.
Gruss HJ; Brach MA; Drexler HG; Bonifer R; Mertelsmann RH; Herrmann F
Cancer Res; 1992 Jun; 52(12):3353-60. PubMed ID: 1596893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
